http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9813063-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5bc5292a07e34d16eb1d033a16d3aec3 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 |
| filingDate | 1997-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27156c204582e3b498e554c843edb816 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dca81fdc68d4d2da5fdf4c0bc9dc8d3 |
| publicationDate | 1998-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9813063-A1 |
| titleOfInvention | Cyclic peptide antitumor agent from an ascidian |
| abstract | A purified bicyclic depsipeptide, vitilevuamide (1), from the ascidians Didemnum cuculliferum and Polysyncraton lithostrotum is disclosed. Vitilevuamide has antitumor activity as demonstrated by standard in vitro and in vivo assays. An anticancer composition is also disclosed, comprising an effective amount of vitilevuamide and an inert carrier. A method of treating cancer in also disclosed, comprising administering an anticancer composition comprising an effective amount of vitilevuamide and an inert carrier. |
| priorityDate | 1996-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 390.